Related Experiment Video

Updated: Apr 10, 2026

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
13:10

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA

Published on: April 24, 2017

19.5K

Interventional Management of Unprotected Left Main Coronary Artery Disease: Patient Selection and Technique

David G Rizik1, Kevin J Klassen1, Robert F Burke1

  • 1The Scottsdale-Lincoln Health Network, Scottsdale Healthcare Hospitals, Scottsdale, Arizona.

Journal of Interventional Cardiology
|June 17, 2015
PubMed

Insights

Drug-eluting stents are emerging as a viable alternative to coronary artery bypass graft surgery for left main coronary artery disease, offering comparable outcomes in select patients. Careful patient selection and procedural technique are crucial for optimal results with percutaneous coronary intervention.

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Surgery

Background:

  • Coronary artery bypass graft (CABG) surgery has historically been the standard treatment for left main coronary artery disease (LMCD).
  • Percutaneous coronary intervention (PCI) using drug-eluting stents (DES) is increasingly considered as an alternative revascularization strategy.

Purpose of the Study:

  • To review clinical evidence comparing outcomes of DES PCI versus CABG for unprotected left main coronary artery disease.
  • To discuss factors influencing the choice between PCI and CABG for LMCD revascularization.
  • To highlight the importance of meticulous technique in PCI for LMCD.

Main Methods:

  • Systematic review of clinical studies and trials.
  • Analysis of patient-specific factors (anatomic complexity, comorbidities).
  • Evaluation of procedural techniques and adjunct therapies for PCI in LMCD.

Main Results:

  • Increasing evidence supports DES PCI as a safe and effective alternative to CABG for select LMCD patients.
  • Outcomes are comparable between PCI and CABG in specific patient subgroups.
  • Meticulous procedural technique, including imaging guidance and optimal stent selection, is critical for successful PCI in LMCD.

Conclusions:

  • DES PCI is a viable and potentially preferred option for revascularization in select patients with unprotected left main coronary artery disease.
  • Shared decision-making considering patient anatomy, comorbidities, and procedural expertise is essential.
  • Further research is needed to address areas of equipoise and optimize treatment strategies for LMCD.

More Related Videos

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

6.2K
Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

4.8K

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
485
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
435
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
421
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
593
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
598
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
481